FOLFOXIRI in patients with colon cancer and isolated non-resectable liver metastases: phase II prospective non-randomized single-center study

FOLFOXIRI in patients with colon cancer and isolated non-resectable liver metastases: phase II prospective non-randomized single-center study

Objective: to assess the frequency of liver resections in patients with metastatic colon cancer and isolated non-resectable liver metastases receiving FOLFOXIRI. Materials and methods. In this single-center non-randomized prospective study, we assessed the frequency of liver resections. According to...

Full description

Bibliographic Details
Main Authors: M. Yu. Fedyanin, E. M. Polyanskaya, I. A. Pokataev, A. A. Tryakin, O. V. Sekhina, D. A. Chekini, Kh.-Kh. M. Elsnukaeva, A. N. Polyakov, I. V. Sagaydak, V. D. Podluzhniy, V. A. Aliev, S. S. Gordeev, D. V. Kuzmichev, Z. Z. Mamedli, S. A. Tjulandin
Format: Article
Language:Russian
Published: “ABV-press” Publishing house”, LLC 2019-11-01
Series:Тазовая хирургия и онкология
Subjects:
colon cancer
metastasectomy
liver resection
folfoxiri
chemotherapy
targeted therapy
Online Access:https://ok.abvpress.ru/jour/article/view/339

Internet

https://ok.abvpress.ru/jour/article/view/339

Similar Items